Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

23 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Induction, mobilization of peripheral blood stem cells (PBSC), high-dose chemotherapy and PBSC infusion in patients with untreated stage IV breast cancer: outcomes by intent to treat analyses.
Weaver CH, West WH, Schwartzberg LS, Alberico T, Leff R, Greco FA, Hainsworth J, Birch R, McAneny B, Magee M, Raefsky E, Kalman L, Buckner CD. Weaver CH, et al. Among authors: raefsky e. Bone Marrow Transplant. 1997 Apr;19(7):661-70. doi: 10.1038/sj.bmt.1700728. Bone Marrow Transplant. 1997. PMID: 9156242 Clinical Trial.
Sequential treatment including high-dose chemotherapy with peripheral blood stem cell support in patients with high-risk stage II-III breast cancer: outpatient administration in community cancer centers.
Schwartzberg LS, Birch R, West WH, Tauer KW, Wittlin F, Leff R, Campos L, Rymer W, Carter P, Mangum M, Greco FA, Hainsworth J, Raefsky E, Blanco R, Buckner CD, Weaver CH. Schwartzberg LS, et al. Among authors: raefsky e. Am J Clin Oncol. 1998 Oct;21(5):523-31. doi: 10.1097/00000421-199810000-00022. Am J Clin Oncol. 1998. PMID: 9781614 Clinical Trial.
Adjuvant dose-intense chemotherapy with peripheral blood stem cell support in stage II-III breast cancer with five to nine involved axillary lymph nodes.
Schwartzberg LS, Birch R, Tauer KW, Leff R, Greco FA, Hainsworth J, Raefsky E, McAneny B, Weaver Z, West J, Buckner CD, Weaver CH. Schwartzberg LS, et al. Among authors: raefsky e. Am J Clin Oncol. 1999 Apr;22(2):136-42. doi: 10.1097/00000421-199904000-00006. Am J Clin Oncol. 1999. PMID: 10199446 Clinical Trial.
Paclitaxel and carboplatin adjuvant therapy alone or with radiotherapy for resected nonsmall cell lung carcinoma: a feasibility study of the Minnie Pearl Cancer Research Network.
Greco FA, Burris HA 3rd, Gray JR, Raefsky EL, Dobbs C, Smith S, Rinaldi D, Morrissey LH, Erland JB, Litchy S, Hainsworth JD. Greco FA, et al. Among authors: raefsky el. Cancer. 2001 Oct 15;92(8):2142-7. doi: 10.1002/1097-0142(20011015)92:8<2142::aid-cncr1556>3.0.co;2-r. Cancer. 2001. PMID: 11596031 Clinical Trial.
Weekly paclitaxel, estramustine phosphate, and oral etoposide in the treatment of hormone-refractory prostate carcinoma: results of a Minnie Pearl Cancer Research Network phase II trial.
Meluch AA, Greco FA, Morrissey LH, Raefsky EL, Steis RG, Butts JA, Hainsworth JD; Minnie Pearl Cancer Research Network. Meluch AA, et al. Among authors: raefsky el. Cancer. 2003 Nov 15;98(10):2192-8. doi: 10.1002/cncr.11790. Cancer. 2003. PMID: 14601089 Free article. Clinical Trial.
23 results